Dr. Guillermo M. Bravo
Claim this profileM D Anderson Cancer Center
Studies Chronic Myelomonocytic Leukemia
Studies Myelodysplastic Syndrome
6 reported clinical trials
10 drugs studied
Area of expertise
1Chronic Myelomonocytic Leukemia
ASXL1 positive
TP53 positive
FLT3 positive
2Myelodysplastic Syndrome
ASXL1 positive
TP53 positive
FLT3 positive
Affiliated Hospitals
Clinical Trials Guillermo M. Bravo is currently running
Combination Chemotherapy
for Chronic Myelomonocytic Leukemia & Myelodysplastic Syndrome
This trial uses a combination of four drugs to treat certain blood cancers in patients who have not responded to other treatments or are at high risk. The drugs work together to kill cancer cells and stop their growth.
Recruiting3 awards Phase 2
Azacitidine + Quizartinib
for Myelodysplastic Syndrome
This phase I/II trial studies the side effects and best dose of quizartinib when given with azacitidine and to see how well they work in treating patients with myelodysplastic syndrome or myelodysplastic/myeloproliferative neoplasm with FLT3 or CBL mutations. Chemotherapy drugs, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Quizartinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving azacitidine and quizartinib may help to control myelodysplastic syndrome or myelodysplastic/myeloproliferative neoplasm.
Recruiting1 award Phase 1 & 2
More about Guillermo M. Bravo
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Guillermo M. Bravo has experience with
- Azacitidine
- Quizartinib
- Seclidemstat
- Decitabine
- Tagraxofusp-erzs
- Cladribine
Breakdown of trials Guillermo M. Bravo has run
Chronic Myelomonocytic Leukemia
Myelodysplastic Syndrome
MDS
CMML
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Guillermo M. Bravo specialize in?
Guillermo M. Bravo focuses on Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome. In particular, much of their work with Chronic Myelomonocytic Leukemia has involved ASXL1 positive patients, or patients who are TP53 positive.
Is Guillermo M. Bravo currently recruiting for clinical trials?
Yes, Guillermo M. Bravo is currently recruiting for 5 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Guillermo M. Bravo has studied deeply?
Yes, Guillermo M. Bravo has studied treatments such as Azacitidine, Quizartinib, Seclidemstat.
What is the best way to schedule an appointment with Guillermo M. Bravo?
Apply for one of the trials that Guillermo M. Bravo is conducting.
What is the office address of Guillermo M. Bravo?
The office of Guillermo M. Bravo is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.